K. Mcneil

发表

Peri‐operative Care of the Heart Transplant Recipient

K. Mcneil, J. Dunning, K. McNeil, 2010 .

Heart-lung transplantation for Eisenmenger syndrome: early and long-term results.

L. Sharples, J. Wallwork, D. Satchithananda, 2001, The Annals of thoracic surgery.

Treatment options and strategies for acute severe pulmonary embolism

C. Hamilton-Craig, D. Walters, R. Slaughter, 2008, Internal medicine journal.

Atrial versus ventricular cannulation for a rotary ventricular assist device.

U. Steinseifer, S. Gregory, J. Fraser, 2010, Artificial organs.

Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation--early risk factors.

L. Sharples, J. Wallwork, M. Tamm, 1996, Transplantation.

Review of bosentan in the management of pulmonary arterial hypertension

E. Gabbay, K. Mcneil, J. Fraser, 2007, Vascular health and risk management.

Pulmonary arterial hypertension: a new era in management

A. Keogh, L. Cleland, E. Gabbay, 2003, The Medical journal of Australia.

Airway stenoses after lung transplantation: management with expanding metal stents.

J. Wallwork, S. Nashef, R. Higgins, 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension

J. Dunning, K. Mcneil, K. McNeil, 1999, Thorax.

An Australian tertiary referral center experience of the management of chronic thromboembolic pulmonary hypertension

P. Hopkins, B. Thomson, K. Mcneil, 2012, Pulmonary circulation.

Microvascular changes in small airways predispose to obliterative bronchiolitis after lung transplantation.

M. Goddard, H. Luckraz, S. Charman, 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Airway complications after lung transplantation: treatment and long-term outcome.

R. Higgins, J. Wallwork, R. Coulden, 2001, The Annals of thoracic surgery.

Comparison of Mycophenolate Mofetil and Azathioprine for Prevention of Bronchiolitis Obliterans Syndrome in De Novo Lung Transplant Recipients

R. Speich, P. Corris, C. Knoop, 2006, Transplantation.

Generic drug immunosuppression in thoracic transplantation: an ISHLT educational advisory.

P. Corris, H. Ross, M. Mehra, 2009, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

In-vitro and In-vivo testing of the BiVACOR Rotary BiVAD/TAH

U. Steinseifer, J. Fraser, D. Timms, 2009 .

The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience.

L. Sharples, J. Parameshwar, D. Satchithananda, 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Is obliterative bronchiolitis in lung transplantation associated with microvascular damage to small airways?

L. Sharples, M. Goddard, H. Luckraz, 2006, The Annals of thoracic surgery.

Familial and sporadic primary pulmonary hypertension is caused by BMPR2 gene mutations resulting in haploinsufficiency of the bone morphogenetic protein tùype II receptor.

P. Corris, R. Trembath, J. Loyd, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

One year analysis of an ongoing international randomized study of mycophenolate mofetil (MMF) vs azathioprine (AZA) in lung transplantation.

G. Verleden, R. Speich, P. Corris, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Resolution of severe ischemia-reperfusion injury post-lung transplantation after administration of endobronchial surfactant.

J. Fraser, P. Hopkins, K. Mcneil, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Atrial septostomy in the treatment of severe pulmonary arterial hypertension

F. Reichenberger, J. Parameshwar, L. Shapiro, 2003, Thorax.

Assessment of survival benefit after lung transplantation by patient diagnosis.

L. Sharples, S. Charman, J. Wallwork, 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Fast track recovery following en bloc heart-lung-liver transplantation in a patient with cystic fibrosis complicated by severe portal hypertension.

I. Konstantinov, K. Mcneil, J. Dunning, 2008, Heart, lung & circulation.

EN BLOC HEART–LUNG–LIVER TRANSPLANTATION IN PATIENTS WITH END-STAGE CYSTIC FIBROSIS

I. Konstantinov, K. Mcneil, J. Dunning, 2007 .

Combined transplantation of the heart, lung, and liver

G. Alexander, P. Friend, R. Calne, 2001, The Lancet.

Public Funding of Bosentan for the Treatment of Pulmonary Artery Hypertension in Australia

R. Weintraub, A. Keogh, L. Cleland, 2012, PharmacoEconomics.

Oil red O stain of alveolar macrophages is an effective screening test for gastroesophageal reflux disease in lung transplant recipients.

E. Duhig, D. Gotley, P. Hopkins, 2010, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Interleukin 1 and Chronic Rejection: Possible Genetic Links in Human Heart Allografts

S. Metcalfe, J. Wallwork, K. Mcneil, 2002, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Genetic modulators of interleukin 1 activity influence the development of chronic rejection in human thoracic allografts.

S. Metcalfe, C. Taylor, K. Mcneil, 2001, Transplantation proceedings.

Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation.

G. Snell, M. Zamora, S. Studer, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Ventricular assist surprise: giant cell myocarditis or sarcoidosis?

M. Goddard, J. Parameshwar, S. Large, 2003, The Journal of thoracic and cardiovascular surgery.

352: Sequential combination therapy in pulmonary arterial hypertension (PAH)

P. Macdonald, C. Hayward, A. Keogh, 2007 .

Improvement after angioplasty and stenting of pulmonary arteries due to sarcoid mediastinal fibrosis.

C. Hamilton-Craig, D. Walters, R. Slaughter, 2009, Heart, lung & circulation.

Evidence for immunosuppression in lung transplantation

P. Hopkins, K. Mcneil, K. McNeil, 2008, Current opinion in organ transplantation.

Randomized, trough blood cyclosporine concentration-controlled trial to compare the pharmacodynamics of Sandimmune and Neoral in de novo lung transplant recipients.

J. Parameshwar, J. Wallwork, A. Trull, 1999, Therapeutic drug monitoring.

Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease

P. Macdonald, C. Hayward, D. Celermajer, 2006, Cardiology in the Young.

Atrial septostomy in the treatment of severe pulmonary arterial hypertension

F. Reichenberger, J. Parameshwar, L. Shapiro, 2003 .

Pulmonary hypertension: into the 21st century

K. Mcneil, 2012, Heart.

Assessment of Patients with Pulmonary Hypertension

K. Mcneil, 2008, Respiration.

Audit of referral and explant diagnoses in lung transplantation: a pathologic study of lungs removed for parenchymal disease.

J. Wallwork, T. Higenbottam, F. Wells, 1995, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Antibiotic prophylaxis for the prevention of donor-acquired Toxoplasma gondii infection in transplant patients.

J. Parameshwar, J. Wallwork, T. Wreghitt, 1995, The Journal of infection.

Suppression of interleukin-8 and myeloperoxidase production in the cerebrovascular bed during repeated deep hypothermic circulatory arrest

D. Menon, A. Vuylsteke, J. Dunning, 2001, Critical Care.

2 The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery

D. Menon, A. Vuylsteke, J. Dunning, 2001 .

Selected abstracts from presentations to the 18 th Spring Meeting of the Association of Cardiothoracic Anaesthetists 22 June 2001 , Cambridge , UK Association of Cardiothoracic Anaesthetists

D. Menon, A. Vuylsteke, J. Dunning, 2022 .

Unexplained chronic anemia and leukopenia in lung transplant recipients secondary to parvovirus B19 infection.

P. Hopkins, K. Mcneil, J. Dunning, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

A complete mock circulation loop for the evaluation of left, right, and biventricular assist devices.

Andrew Galbraith, Daniel Timms, Mark Hayne, 2005, Artificial organs.

Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.

Gerald J Berry, Elaine F Reed, Charles C Marboe, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Risk factors for bronchiolitis obliterans: a systematic review of recent publications.

L. Sharples, J. Wallwork, K. Mcneil, 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Graft-versus-host disease in lung transplantation: 4 case reports and literature review.

H. Luckraz, J. Wallwork, K. Mcneil, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Extended ganciclovir prophylaxis in lung transplantation.

S. Charman, J. Wallwork, T. Wreghitt, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients

L. Sharples, N. Cary, J. Parameshwar, 1999, Transplant international : official journal of the European Society for Organ Transplantation.

Cytomegalovirus antibody status of donor/recipient does not influence the incidence of bronchiolitis obliterans syndrome in lung transplantation.

L. Sharples, H. Luckraz, J. Wallwork, 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors.

D Heng, L. Sharples, J. Wallwork, 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

A model for analyzing the cost of the main clinical events after lung transplantation.

J Karnon, L. Sharples, M. Buxton, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The pulmonary physician in critical care c 13: The pulmonary circulation and right ventricular failure in the ITU

K McNeil, J Dunning, N W Morrell, 2003 .

International guidelines for the selection of lung transplant candidates. The American Society for Transplant Physicians (ASTP)/American Thoracic Society(ATS)/European Respiratory Society(ERS)/International Society for Heart and Lung Transplantation(ISHLT).

Keith McNeil, Robyn J. Barst, Stuart Rich, 1998, American journal of respiratory and critical care medicine.

BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

M. Humbert, P. Corris, R. Trembath, 2001, American journal of human genetics.

Acute and chronic onset of bronchiolitis obliterans syndrome (BOS): are they different entities?

Keith McNeil, Christopher H Jackson, Linda D Sharples, 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

The BiVACOR rotary biventricular assist device: concept and in vitro investigation.

John Fraser, Daniel Timms, Mark Hayne, 2008, Artificial organs.

Excellent outcome of cardiac transplantation using domino donor hearts.

J. Wallwork, J. Smith, S. Large, 1996, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Significance of graft coronary artery disease in heart-lung transplant recipients.

J. Wallwork, J. Smith, S. Large, 1995, Transplantation proceedings.

Predictive utility of the 6-minute walk distance on survival in patients awaiting lung transplantation.

J. Paratz, P. Hopkins, K. Mcneil, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Endothelin receptor antagonists are an effective long term treatment option in pulmonary arterial hypertension associated with congenital heart disease with or without trisomy 21.

D. Radford, K. Mcneil, F. Kermeen, 2010, Heart, lung & circulation.

Quality of life in pulmonary arterial hypertension: improvement and maintenance with bosentan.

A. Keogh, E. Gabbay, K. Mcneil, 2007, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Bosentan therapy in patients with pulmonary arterial hypertension: The relationship between improvements in 6 minute walk distance and quality of life

A. Keogh, G. Strange, E. Gabbay, 2008, Respirology.

Chronic thromboembolic pulmonary hypertension (CTEPH)

Keith McNeil, K. Mcneil, J. Dunning, 2007, Heart.

Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart‐lung, and lung transplant recipients

N. Cary, J. Parameshwar, J. Wallwork, 1999 .

Lung Transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital.

J. Wallwork, J. Smith, T. Higenbottam, 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Pulmonary hypertension and left heart disease: emerging concepts and treatment strategies

D. O’Callaghan, K. Mcneil, K. McNeil, 2008, International journal of clinical practice. Supplement.